Boulder, CO, United States of America

Mark A Schwindt


Average Co-Inventor Count = 8.3

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2003-2008

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Mark A. Schwindt: A Pioneer in Peptide Synthesis

Introduction

Mark A. Schwindt, based in Boulder, Colorado, is a notable inventor recognized for his significant contributions to the field of peptide synthesis. With a portfolio of five patents, Schwindt has developed innovative processes that have the potential to advance biochemical research and pharmaceutical applications.

Latest Patents

Among his latest patents is a groundbreaking invention focusing on "Process and Systems for Peptide Synthesis." This invention details methods for synthesizing peptides by starting with a peptide fragment that includes a base-sensitive, N-terminal protecting group. The procedure outlines a systematic approach involving the removal of this protecting group with a deprotection reagent containing a base, leading to a deprotected N-terminal functionality ready for further reactions. The patent includes techniques for ensuring the residual base content remains above 100 ppm and methods that allow coupling of reactive peptide fragments under basic conditions.

Another notable patent from Schwindt is related to the "Synthesis of 3,6-Dialkyl-5,6-Dihydro-4-hydroxy-Pyran-2-One." This patent describes a novel process for producing a δ-lactone using specific acyl halides, along with novel intermediates. The process is particularly innovative as it aims for the enantioselective production of the (R)-δ-lactone, showcasing Schwindt's expertise in synthetic organic chemistry.

Career Highlights

Throughout his career, Mark A. Schwindt has made significant strides in the pharmaceutical industry, holding positions at renowned companies such as Roche Colorado Corporation and Roche Palo Alto LLC. His work in these organizations has positioned him as a key contributor to advancements in peptide synthesis technologies.

Collaborations

Schwindt has collaborated with notable scientists in his field, including Lewis M. Hodges and David A. Johnston. These partnerships have fostered a collaborative research environment, enhancing the development of innovative solutions within the realm of peptide synthesis.

Conclusion

Mark A. Schwindt’s contributions to the field of peptide synthesis through his patents underline his role as an influential inventor. With continued research and innovation, Schwindt remains a significant figure in advancing technologies that could lead to breakthroughs in medicinal chemistry and related fields. His work exemplifies the impact of inventors in shaping the future of science and industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…